NCT05794698Completed
Intraoperative Frozen Section Pathology to Diagnose the IASLC Grades for Lung Adenocarcinoma (ECTOP-1014)
Concordance Between Intraoperative Frozen Section and Postoperative Pathology in Diagnosing the IASLC Grades and Guiding the Surgical Procedure of Lung Adenocarcinoma: a Multi-center Prospective Study
Source: ClinicalTrials.gov · Last updated 3 Sept 2024
Brief summary (registry, in English)
This study is one of Eastern Cooperative Thoracic Oncology Projects (ECTOP-1014). The goal of this clinical trial is to confirm the concordance rate between intra-operative frozen section pathological diagnosis and post-operative paraffin embedded pathological diagnosis, and use this result to guide surgical treatment for early stage (cT1N0M0) lung adenocarcinomas.
- Status (registry)
- Completed
- Study type
- Observational
- Enrollment
- 827 (actual)
- First submitted
- 8 Mar 2023
- Start date
- 1 Jan 2022
- Primary completion date
- 30 Jun 2024
- Lead sponsor
- Fudan University
- Diseases
- Lung cancer, Childhood cancers
- NCT number
- NCT05794698
What you commit to
- Study type: Observational
- Participants enrolled: 827
- From 1 Jan 2022 to the primary completion date, 30 Jun 2024
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Patients having received radiation therapy or chemotherapy.
Other illness
- Previous history of cancer;
Other
- Patients with clinical stages other than T1N0M0;
- The lesion cannot be completely resected;
Who the study is looking for
- Patients who sign the informed consent form and are willing to complete the study according to the study protocol;
- No previous history of cancer or pulmonary surgery;
- Solitary lesions or multiple lesions with only one not manifesting as pure ground-glass opacity (GGO) on CT scan;
- Peripheral clinical T1N0M0 patients that are eligible for surgery;
- Non-small cell lung cancer is pathologically diagnosed before or at surgery;
- No radiation therapy or chemotherapy before surgery.
Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Fudan University Cancer Center Coordinator of this site? Confirm its status | Shanghai | China | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.